The Effect of Preoperative Gabapentin on Postoperative Pain Control and Analgesic Requirements Following Bariatric Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The importance of bariatric anesthesia and analgesia research cannot be ignored as it can inform and improve the perioperative protocols for other patients with morbid obesity irrespective of the surgical procedures they are undergoing

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve Gastrectomy

NCT05921604

Post Operative Pain

ACTIVE_NOT_RECRUITING PHASE3

Study Effects of Preoperative Modafinil on Recovery Profile of Morbidly Obese Patients Scheduled for Bariatric Surgery if it Can Enhance Recovery From Anesthesia

NCT07128719

Obese Adolescents Bariatric Surgery

COMPLETED NA

The EFFICIENCY of FASCIAL PLANE BLOCKS in BARIATRIC SURGERY

NCT05284695

Regional Anesthesia Morbidity Post Operative Pain Bariatric Surgery Candidate

COMPLETED

The Interest of the ANI in the Monitoring of Peroperative Analgesia in Bariatric Surgery

NCT03103698

Surgery Obese

COMPLETED NA

Ketamine in Bariatric Surgery

NCT01724983

Morbid Obesity

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Among various postoperative complications, pain is the main adverse event experienced by patients. Good control of postoperative pain is an important factor for reducing early postoperative complications such as pulmonary embolism, deep vein thrombosis, ileus, and respiratory infections, and for decreasing length of stay, lowering costs, and increasing patient satisfaction

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgery Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Assuming an effect size of 0.5 for preoperative gabapentin, a sample of 51 patients in each group would be enough to detect such effect, if true, at 0.05 alpha error and 0.80 power of the test

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Single

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Will receive a single dose of gabapentin 300 mg preoperatively before standard general anesthesia

Group Type EXPERIMENTAL

Group 1

Intervention Type DRUG

Will receive a single dose of gabapentin 300 mg preoperatively before standard general anesthesia

Group 2

will receive a placebo before standard general anesthesia

Group Type PLACEBO_COMPARATOR

Group 2

Intervention Type DRUG

will receive a placebo before standard general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group 1

Will receive a single dose of gabapentin 300 mg preoperatively before standard general anesthesia

Intervention Type DRUG

Group 2

will receive a placebo before standard general anesthesia

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Gabapentin 300 Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with American Society of Anesthesiologists physical status ASA I to III
* both genders
* Morbid obese scheduled for bariatric surgery

Exclusion Criteria

* patients with impaired liver or kidney disease
* patients with history of hypersensitivity to gabapentin
* patients with history of alcohol abuse, chronic pain or frequent use of analgesic
* patients with uncontrolled medical disease

Eligible Sex

ALL

Accepts Healthy Volunteers

No